EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role and Mechanism of Incretins in Gynaecologic Diseases

Jiayu Yan iD, Minyue Cao, Yan Ding, Yiqin Zhang iD, Yihan Sun, Genyi Jiang, Yanli Zhang iD, Luyao Kang, Xue Zhou, Jing Luo, Bilan Li iD

Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)

DOI: 10.1002/edm2.70340 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 25.09.2026. Verfasst von Jiayu Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity …. Hauptthemen laut MEDLINE: Incretins, Genital Diseases, Female. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Pujiang Program, Shanghai Medical Star of Tomorrow Youth Medical Talent Development Funding Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is a major global public health concern closely linked to the development and progression of various gynaecological disorders, particularly polycystic ovary syndrome (PCOS) and endometrial cancer. Incretins, a group of gut‐derived hormones primarily including glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP), are widely recognised for their roles in glycemic control and insulin secretion. Accumulating evidence reveals that GLP‐1 and GIP also participate in modulating inflammation, autophagy, immune response and gut‐brain communication through multiple signalling pathways, thereby playing important roles in female reproductive disorders. This review provides a comprehensive overview of the mechanisms and therapeutic potential of incretins in gynaecological conditions.

Methods

We performed a comprehensive literature search across PubMed, Web of Science and Embase, covering studies published from January 1995 to July 2026. Search terms combined incretin‐related keywords (GLP‐1, GIP, GLP‐1 receptor agonists) with gynaecological disease terms (polycystic ovary syndrome, endometriosis, endometrial cancer, ovarian cancer, intrauterine adhesion). We primarily included original research studies and authoritative reviews, and excluded meeting abstracts, case reports and non‐English literature.

Results

GLP‐1 receptor agonists (GLP‐1 RAs) exert multi‐faceted benefits in PCOS, endometriosis, intrauterine adhesions and gynaecologic cancers through cAMP/PKA, PI3K and AMPK signalling pathways. Special emphasis is placed on the multi‐faceted benefits of GLP‐1 RAs, while evidence supporting GIP‐based therapies in gynaecology remains relatively limited and largely preclinical. The current status of clinical application, safety considerations and future directions are further discussed.

Conclusion

Incretin‐based therapies offer novel approaches for metabolic and oncological gynaecological diseases, with significant translational value. Large‐scale clinical studies and deeper mechanistic exploration are warranted to realise their full therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IncretinsGenital Diseases, FemaleHumansFemalePolycystic Ovary SyndromeGastric Inhibitory PolypeptideAnimalsSignal TransductionGlucagon-Like Peptide 1Endometriosis

Stichwörter der Autor:innen

GLP‐1gynaecological cancersincretinsinsulin resistancepolycystic ovary syndrome

Substanzen

IncretinsGastric Inhibitory PolypeptideGlucagon-Like Peptide 1

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai,…

ORCID-Profile: Jiayu Yan, Yiqin Zhang, Yanli Zhang, Bilan Li

Förderung

  • National Natural Science Foundation of China
  • Shanghai Pujiang Program
  • Shanghai Medical Star of Tomorrow Youth Medical Talent Development Funding Program
  • Shanghai Shenkang Hospital Development Center
  • Shanghai Oriental Talents
  • Clinical Research Program of Shanghai First Maternity and Infant Hospital
  • Shanghai Municipal Hospital Development Center

Zitieren

APA

Yan, J., Cao, M., Ding, Y., Zhang, Y., Sun, Y., Jiang, G., Zhang, Y., Kang, L., Zhou, X., Luo, J., & Li, B. (2026). The Role and Mechanism of Incretins in Gynaecologic Diseases. Endocrinology, Diabetes & Metabolism, 9(5). https://doi.org/10.1002/edm2.70340

Vancouver

Yan J, Cao M, Ding Y, Zhang Y, Sun Y, Jiang G, et al. The Role and Mechanism of Incretins in Gynaecologic Diseases. Endocrinology, Diabetes & Metabolism. 2026;9(5). doi:10.1002/edm2.70340

BibTeX
@article{Yan2026,
  author = {Yan, Jiayu and Cao, Minyue and Ding, Yan and Zhang, Yiqin and Sun, Yihan and Jiang, Genyi and Zhang, Yanli and Kang, Luyao and Zhou, Xue and Luo, Jing and Li, Bilan},
  title = {The Role and Mechanism of Incretins in Gynaecologic Diseases},
  journal = {Endocrinology, Diabetes & Metabolism},
  year = {2026},
  volume = {9},
  number = {5},
  doi = {10.1002/edm2.70340}
}
Kostenlos starten →